Imaging as a biomarker in drug discovery for Alzheimer's disease: is MRI a suitable technology?
This review provides perspectives on the utility of magnetic resonance imaging (MRI) as a neuroimaging approach in the development of novel treatments for Alzheimer's disease. These considerations were generated in a roundtable at a recent Wellcome Trust meeting that included experts from acade...
Main Authors: | Merlo Pich, E, Jeromin, A, Frisoni, G, Hill, D, Lockhart, A, Schmidt, M, Turner, M, Mondello, S, Potter, W |
---|---|
格式: | Journal article |
语言: | English |
出版: |
BioMed Central
2014
|
相似书籍
-
Advances in Cardiovascular Biomarker Discovery
由: Crystal M. Ghantous, et al.
出版: (2020-11-01) -
Multinuclear MRI in Drug Discovery
由: Dorota Bartusik-Aebisher, et al.
出版: (2022-10-01) -
Open drug discovery in Alzheimer's disease
由: Alison D. Axtman, et al.
出版: (2023-04-01) -
Artificial intelligence for biomarker discovery in Alzheimer's disease and dementia
由: Winchester, LM, et al.
出版: (2023) -
The role of fMRI in drug discovery.
由: Wise, R, et al.
出版: (2006)